Cargando…

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report

Detalles Bibliográficos
Autores principales:	Fox, Henrik, Gummert, Jan F., Sommer, Philipp, Knabbe, Cornelius, Sohns, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2022
Materias:	COVID-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8890408/ https://www.ncbi.nlm.nih.gov/pubmed/34622432 http://dx.doi.org/10.5603/CJ.a2021.0119

Ejemplares similares

The Evidence for High-Titer Convalescent Plasma in SARS-CoV-2
por: Fisher, David L., et al.
Publicado: (2021)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Addition of levosimendan to overcome acute cardiogenic shock—Paving the way for later heart transplantation—A first case report
por: Flottmann, Christian, et al.
Publicado: (2020)

Cardiogenic Shock Caused by SARS-CoV-2 in a Patient with Serial Negative Nucleic Acid Amplification Tests. Case Report
por: Gomila-Grange, Aina, et al.
Publicado: (2020)

A Review of Viral Shedding in Resolved and Convalescent COVID-19 Patients
por: Karia, Rutu, et al.
Publicado: (2020)

Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection
por: Hou, Hongyan, et al.
Publicado: (2021)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals
por: Li, Min, et al.
Publicado: (2022)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients
por: Grossini, Elena, et al.
Publicado: (2020)

Rapidly Establishing a Hospital-Based Convalescent Plasma Collection Center With the Alyx Apheresis Collection Device
por: Klein, Tovah, et al.
Publicado: (2021)

Convalescent Plasma – Is it Useful for Treating SARS Co-V2 infection?
por: Ranganathan, Sudha, et al.
Publicado: (2020)

Coronavirus (COVID-19) Pandemic and Health Workers of an Ethnic Group—A Slant on a Shocking Report
por: Barsoum, Zakaria
Publicado: (2020)

Characterization of memory T cell subsets and common γ−chain cytokines in convalescent COVID‐19 individuals
por: Rajamanickam, Anuradha, et al.
Publicado: (2022)

COVID-19–associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome—the superantigen hypothesis
por: Noval Rivas, Magali, et al.
Publicado: (2021)

Elevated plasma sTIM-3 levels in patients with severe COVID-19
por: Ueland, Thor, et al.
Publicado: (2021)

A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19: Is Plasma Exchange an Alternative?
por: Ramos-Ruperto, L., et al.
Publicado: (2021)

Management of a Hospital-Wide COVID-19 Outbreak Affecting Patients and Healthcare Workers
por: Höring, Steffen, et al.
Publicado: (2020)

Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
por: Yang, Yang, et al.
Publicado: (2020)

Health Professionals’ Perspectives of the Role of Palliative Care During COVID-19: Content Analysis of Articles and Blogs Posted on Twitter
por: Singh, Gursharan K., et al.
Publicado: (2021)

Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
por: Chen, Yu-Wen, et al.
Publicado: (2022)

ANÁLISE DE CITOCINAS E QUIMIOCINAS NO PLASMA DE PACIENTES COM COVID-19 E DOADORES DE SANGUE ASSINTOMÁTICOS INFECTADOS COM SARS-COV-2
por: Chaves, DG, et al.
Publicado: (2021)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Synergistic Disparities and Public Health Mitigation of COVID-19 in the Rural United States
por: Chillag, Kata L., et al.
Publicado: (2020)

Mitigation Strategies to Reduce Aerosolization of SARS-CoV-2
Publicado: (2022)

Statistical Deconvolution for Inference of Infection Time Series
por: Miller, Andrew C., et al.
Publicado: (2022)

Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination
por: Tomayko, Mary M., et al.
Publicado: (2021)

Credible Protein Targets and Curative Strategies for COVID-19: a Review
por: Singh, Priya, et al.
Publicado: (2020)

A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19
por: Cimolai, Nevio
Publicado: (2020)

Three-Tiered COVID-19 Cohorting Strategy and Implications for Memory-Care
por: Collison, Maggie, et al.
Publicado: (2020)

Preprocedural Pool Testing Strategy for Dentistry during the COVID-19 Pandemic
por: Umer, F., et al.
Publicado: (2021)

Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort
por: Reilev, Mette, et al.
Publicado: (2020)

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
por: Omerovic, Elmir, et al.
Publicado: (2010)

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Management of Dysphagia in Nursing Homes During the COVID-19 Pandemic: Strategies and Experiences
por: Fong, Raymond, et al.
Publicado: (2020)

Managing the COVID-19 Pandemic: Research Strategies Based on the Evolutionary and Molecular Characteristics of Coronaviruses
por: Majid, Sabhiya, et al.
Publicado: (2020)

Building a PPE Monitor Team as Part of a Comprehensive COVID-19 Prevention Strategy
por: Summerlin-Long, Shelley, et al.
Publicado: (2021)

Impact of the COVID-19 Lockdown Strategy on Vascular Surgery Practice: More Major Amputations than Usual
por: Schuivens, Puck M.E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_382se9vu618ddjq4e8mbvjnqa9